Showing results (41-50 of 108) with videos related to
Sort By:
Pageof 11
Science Advances|January 20, 2023
Inflammation of the retinal pigment epithelium drives early-onset photoreceptor degeneration in <i>Mertk</i>-associated retinitis pigmentosaMaria E Mercau, Yemsratch T Akalu, Francesca Mazzoni, et al.The EMBO Journal|June 11, 2013
The kinesin KIF16B mediates apical transcytosis of transferrin receptor in AP-1B-deficient epitheliaAndres E Perez Bay, Ryan Schreiner, Francesca Mazzoni, et al.Molecules (Basel, Switzerland)|October 13, 2021
Association of Systemic Steroid Treatment and Outcome in Patients Treated with Immune Checkpoint Inhibitors: A Real-World AnalysisAgnese Paderi, Elisabetta Gambale, Cristina Botteri, et al.Oncology Research|December 30, 2024
Genetic signatures of <i>ERCC1</i> and <i>ERCC2</i> expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapyEnrico Caliman, Sara Fancelli, Federico Scolari, et al.Frontiers in Oncology|September 26, 2025
KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLCAlessandro Tubita, Sara Fancelli, Lorenzo Anela, et al.Clinical Lung Cancer|November 19, 2019
Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNAMarzia Del Re, Iacopo Petrini, Francesca Mazzoni, et al.British Journal of Cancer|November 9, 2018
Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation studyCarmelo Tibaldi, Andrea Camerini, Marcello Tiseo, et al.Cancer Treatment and Research Communications|July 6, 2022
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapyEnrico Caliman, Sara Fancelli, Carlotta Ottanelli, et al.Journal of Clinical Medicine|July 13, 2024
Efficacy and Safety of Chemotherapy after Immunotherapy in Patients with Advanced Non-Small-Cell Lung CancerAndrea Camerini, Francesca Mazzoni, Vieri Scotti, et al.Oncology Letters|November 2, 2020
<i>ROS1</i> rearrangements are uncommon in biliary tract cancersFrancesca Mazzoni, Paolo Petreni, Enrico Vasile, et al.Pageof 11